跳至主要内容
临床试验/ACTRN12619001046190
ACTRN12619001046190已完成未知

The metabolic effects of endocrine therapy in postmenopausal women with oestrogen-receptor-positive breast cancer

The Department of Medicine, Austin Hospital0 个研究点目标入组 105 人开始时间: 2019年7月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
50 Years 至 85 Years(—)
性别
Female

入选标准

  • Non-metastatic breast cancer
  • -Postmenopausal
  • -Aged 50-85yrs
  • -To commence endocrine therapy treatment intended for at least 12 months
  • -ECOG less than or equal to 1
  • -Ability to consent for study and comply with the study protocol requirements

排除标准

  • -Previous exposure to endocrine therapy (greater than 8 weeks prior to recruitment)
  • -If endocrine therapy stops or changes
  • -Established type 2 diabetes mellitus
  • -Continuous glucocorticoid therapy for less than or equal to 2 weeks within 6 months of study
  • -Hormone replacement therapy within 3 months of study
  • -Any disease which is likely to lead to serious illness or death within the study period

研究者

发起方
The Department of Medicine, Austin Hospital

相似试验

进行中(未招募)
不适用
Effects on Endocrine-Metabolic Parameters and Body Composition of the Addition of Low-Dose Pioglitazone to Flutamide-Metformin Therapy in Young Women with Hyperinsulinemic Ovarian Hyperandrogenism and Cardiovascular Risk - Pioglitazone in PCOSPolycystic Ovary Syndrome includes anovulatory hyperandrogenism, hyperinsulinemia and/or dyslipidemia. Adiponectin and interleukin-6 are adipocytokines that have been related to abdominal fat excess and/or impaired insulin sensitivity. These cytokines -together with other indices of low-grade inflammation-, sucj as C-reactive protein (CRP), and the neutrophil count, contribute to link insulin-resistant states with cardiovascular disease risks.
EUCTR2005-004163-39-ESHospital Sant Joan de Déu40
撤回
3 期
The effect of non-steroidal anti-inflammatory drugs on hormones and metabolism in overweight men with low testosterone and obstructive sleep apnea (optional partner participation)
ACTRN12612000536864Woolcock20
招募中
4 期
The neuroendocrine and metabolic effects of oestrogenseuroendocrine regulation of GH secretion by oestrogensMetabolic effects of oestrogensNeuroendocrine regulation of GH secretion by oestrogensMetabolic and Endocrine - Normal metabolism and endocrine development and function
ACTRN12611001093976Garvan Institute of Medical Research20
已完成
不适用
Impact of endocrine therapy on lipid metabolism and bone metabolism of prostate cancer patients -Comparison with chlormadinone acetate and bicalutamideProstate cancer
JPRN-UMIN000018478agasaki University Hospital100
招募中
不适用
To study the endocrine and metabolic characteristics in different phenotypes of PCOS
CTRI/2023/01/049008ESIPGIMSR Basaidarapur Delhi